Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Positive    save search

Blueprint Medicines to Present Positive Data from PIONEER Trial of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis at 2023 AAAAI Annual Meeting
Published: 2023-02-03 (Crawled : 14:20) - prnewswire.com
BPMC | $45.64 -6.97% -7.49% 810K twitter stocktwits trandingview |
Health Technology
| | O: 5.37% H: 0.0% C: 0.0%

ayvakit meeting trial positive
INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®)
Published: 2023-02-02 (Crawled : 14:00) - biospace.com/
INO | $1.915 6.98% 6.53% 8.8M twitter stocktwits trandingview |
Health Technology
| | O: 6.17% H: 0.0% C: 0.0%

ino-4201 ervebo ebola for positive results
Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (axitinib injectable suspension) in Wet AMD
Published: 2023-02-02 (Crawled : 12:20) - globenewswire.com
CLSD | $1.525 2.35% 2.3% 410K twitter stocktwits trandingview |
Health Technology
| | O: 16.9% H: 0.0% C: 0.0%

cls-ax extension positive results study
American Lithium Announces Positive Preliminary Economic Assessment for TLC, Base Case – After-tax NPV8% US$3.26 Billion & After-tax IRR of 27.5%
Published: 2023-02-01 (Crawled : 12:00) - americanlithiumcorp.com
AMLI | $3.49 -1.69% -1.72% 470K twitter stocktwits trandingview |
n/a
| | O: 4.27% H: 2.73% C: -0.55%

for lithium positive
TransCode Therapeutics Reports Positive Preclinical Results with its Immunotherapy Candidate, TTX-RIGA, in Melanoma Study provides additional support for further advancement of TTX-RIGA
Published: 2023-01-31 (Crawled : 23:00) - biospace.com/
RNAZ | $0.6304 -4.5% -4.71% 570K twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist

melanoma preclinical immunotherapy for therapeutics positive results study
TransCode Therapeutics Reports Positive Preclinical Results with its Immunotherapy Candidate, TTX-RIGA, in Melanoma
Published: 2023-01-31 (Crawled : 22:00) - globenewswire.com
RNAZ | $0.6304 -4.5% -4.71% 570K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 37.19% H: 3.88% C: -15.44%

melanoma preclinical immunotherapy therapeutics positive results
Conformal Medical Announces Positive One-Year Data from its Left Atrial Appendage Closure Performed Under Conscious Sedation Study
Published: 2023-01-31 (Crawled : 22:00) - prnewswire.com
MS | News | $99.43 0.22% -0.07% 6.9M twitter stocktwits trandingview |
Finance
| | O: 0.67% H: 2.18% C: 1.28%

medical positive study
Skye Bioscience Achieves Positive Safety Review of SBI-100 Ophthalmic Emulsion After Phase 1 First Cohort
Published: 2023-01-31 (Crawled : 15:20) - biospace.com/
SKYE | $0.0503 0 twitter stocktwits trandingview |
Transportation and Warehousing
| Email alert Add to watchlist

sbi-100 review positive bioscience
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
Published: 2023-01-31 (Crawled : 15:00) - biospace.com/
EDAP | $10.84 0.74% 0.74% 27K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

treatment for positive results study
Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound
Published: 2023-01-31 (Crawled : 15:00) - biospace.com/
CMNDD | $7.9 twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
CMND | $3.68 0.0% 35K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist
CMNDF | $ 0% twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist

pre-clinical biotech positive results depression
Valbiotis Announces Positive Results in the Bioavailability and Mode of Action TOTUM•854 Clinical Study, Against High Blood Pressure
Published: 2023-01-30 (Crawled : 17:00) - biospace.com/
PPRUF | $639.4 0 twitter stocktwits trandingview |
Consumer Non-Durables
| Email alert Add to watchlist
PPRUY | $64.525 0 twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

blood positive results
CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs
Published: 2023-01-30 (Crawled : 15:00) - biospace.com/
CVAC | $11.055 -5.35% -5.65% 540K twitter stocktwits trandingview |
Health Technology
| | O: 5.54% H: 0.0% C: 0.0%

covid-19 vaccine mrna positive
CureVac veröffentlicht positive Daten bei älteren Erwachsenen aus COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen
Published: 2023-01-30 (Crawled : 12:20) - curevac.com
GSK | $34.83 -0.85% 0.03% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.84% H: 0.0% C: 0.0%
CVAC | $11.055 -5.35% -5.65% 540K twitter stocktwits trandingview |
Health Technology
| | O: 5.54% H: 0.0% C: 0.0%

covid-19 positive
Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab biosimilar
Published: 2023-01-30 (Crawled : 07:00) - globenewswire.com
NVS | $85.85 -0.29% -0.29% 3.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.86% H: 0.0% C: 0.0%

biosimilar for chmp positive
Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent (NTD) Beta Thalassemia
Published: 2023-01-27 (Crawled : 13:00) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.0% C: 0.0%

reblozyl for chmp positive
Bristol Myers Squibb Announces Positive CHMP Opinion for Once-Daily Sotyktu (deucravacitinib) as a Treatment for Adults With Moderate-to-Severe Plaque Psoriasis
Published: 2023-01-27 (Crawled : 13:00) - biospace.com/
BMY A | $74.45 2.31% -0.54% 10M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.0% C: 0.0%
AMGN | $245.12 -0.57% -0.58% 3.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.0% C: 0.0%

treatment for chmp psoriasis positive
Insights on the Envelope Tracking Chips Global Market to 2027: Significant Growth in the Electronics Industry Across the Globe is Creating a Positive Outlook
Published: 2023-01-26 (Crawled : 00:00) - prnewswire.com
KEYS | $181.4 -0.43% 0.0% 710K twitter stocktwits trandingview |
Electronic Technology
| | O: -1.25% H: 0.0% C: 0.0%
TXN F | $182.28 -1.32% -1.34% 5.7M twitter stocktwits trandingview |
Electronic Technology
| | O: -1.76% H: 0.0% C: 0.0%
QCOM | $135.05 -0.59% -0.59% 13M twitter stocktwits trandingview |
Electronic Technology
| | O: -1.91% H: 0.0% C: 0.0%
AVGO | $597.65 -1.34% -1.36% 1.9M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.14% H: 0.0% C: 0.0%

global electronics positive growth market
AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
Published: 2023-01-26 (Crawled : 12:20) - globenewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.48% H: 0.34% C: -0.85%
ACIU | $2.42 -2.42% -2.48% 86K twitter stocktwits trandingview |
Health Technology
| | O: 14.1% H: 0.0% C: -7.34%

aci-24 for vaccine trial alzheimer’s positive aci-24.060 anti-amyloid beta
Enlivex Announces Positive DSMB Recommendation and IMOH Clearance to Continue Phase I/II Trial of Allocetra in Patients with Advanced Solid Tumors
Published: 2023-01-25 (Crawled : 14:00) - globenewswire.com
ENLV | $4.37 0.23% 0.0% 21K twitter stocktwits trandingview |
Health Technology
| | O: 4.42% H: 0.0% C: 0.0%

clearance trial tumors positive
Capricor Therapeutics Announces Positive 18-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy Patients
Published: 2023-01-25 (Crawled : 13:00) - globenewswire.com
CAPR | $4.15 -1.19% -1.2% 60K twitter stocktwits trandingview |
Health Technology
| | O: -2.72% H: 0.0% C: 0.0%

cap-1002 ongoing label extension therapeutics duchenne positive results study
Gainers vs Losers
62% 38%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.